CRDF FY 2025 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$139M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$593,000-13.2% YoY

Gross Profit

-$311,000-52.4% margin

Operating Income

-$49M-8256.3% margin

Net Income

-$46M-7736.3% margin

EPS (Diluted)

$-0.69

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$62M

Total Liabilities

$16M

Stockholders' Equity

$45M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$593,000	$683,000	-13.2%
Gross Profit	-$311,000	$683,000	-145.5%
Operating Income	-$49M	-$49M	-0.6%
Net Income	-$46M	-$45M	-1.0%